Old Web
English
Sign In
Acemap
>
authorDetail
>
Raymond Urbanski
Raymond Urbanski
Internal medicine
Medicine
Oncology
Essential thrombocythemia
Second-line therapy
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Design of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea (HU)
2021
Blood
Jie Jin
Lei Zhang
Su-Jiang Zhang
Suning Chen
Minghui Duan
Jingjing Zhang
Wei Wang
Warren Shen
Oleh Zagrijtschuk
Raymond Urbanski
Albert Qin
Zhijian Xiao
Show All
Source
Cite
Save
Citations (0)
Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia
2021
Blood
Ruben A. Mesa
Norio Komatsu
Harinder Gill
Jie Jin
Sung-Eun Lee
Hsin-An Hou
Toshiaki Sato
Albert Qin
Raymond Urbanski
Weichung Shih
Oleh Zagrijtschuk
Craig Zimmerman
Srdan Verstovsek
Show All
Source
Cite
Save
Citations (0)
1